Dr Xavier Hiram Quinones De Jesus, MD in Yauco, PR - Medicare Ophthalmology

Dr Xavier Hiram Quinones De Jesus, MD is a medicare enrolled "Ophthalmology" physician in Yauco, Puerto Rico. He graduated from medical school in 2014 and has 10 years of diverse experience with area of expertise as Ophthalmology. His current practice location is 550 Carr 128 Ste 106, Yauco, Puerto Rico. You can reach out to his office (for appointments etc.) via phone at (787) 267-7829.

Dr Xavier Hiram Quinones De Jesus is licensed to practice in Puerto Rico (license number 19475) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1427475748.

Contact Information

	Dr Xavier Hiram Quinones De Jesus, MD
	550 Carr 128 Ste 106, Yauco, PR 00698-4435
	(787) 267-7829
	Not Available

Physician's Profile

Full Name	Dr Xavier Hiram Quinones De Jesus
Gender	Male
Speciality	Ophthalmology
Experience	10 Years
Location	550 Carr 128 Ste 106, Yauco, Puerto Rico
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Xavier Hiram Quinones De Jesus graduated from medical school in 2014

NPI Data:

NPI Number: 1427475748
Provider Enumeration Date: 03/25/2014
Last Update Date: 10/18/2020

Medicare PECOS Information:

PECOS PAC ID: 6709206006
Enrollment ID: I20201026000196

Medical Identifiers

Medical identifiers for Dr Xavier Hiram Quinones De Jesus such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1427475748	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207W00000X	Ophthalmology	19475 (Puerto Rico)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Xavier Hiram Quinones De Jesus is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Xavier Hiram Quinones De Jesus, MD 8024 Calle Concordia Ste 200, Santa Maria, Ponce, PR 00717 Ph: (787) 842-2040	Dr Xavier Hiram Quinones De Jesus, MD 550 Carr 128 Ste 106, Yauco, PR 00698-4435 Ph: (787) 267-7829

News Archive

Synergetics anticipates $13 million net sales for fourth quarter 2010

Synergetics USA, Inc., a medical device company that designs, manufactures, and markets innovative microsurgical instruments for ophthalmic and neurosurgical applications, today announced that it expects to report net sales of approximately $13 million and net income of approximately $1 million for its fourth quarter ended July 31, 2010.

WHA endorses interim targets to eradicate measles as WHO warns disease on the rise

"Measles is making a rapid comeback in African, Asian and even some European countries despite being easily avoided through vaccination, the World Health Organization said Friday as countries pledged to sharply cut infections and deaths worldwide by 2015," the Associated Press reports (Jordans, 5/22). On the final day of the 63rd Annual World Health Assembly, the assembly endorsed a series of interim targets towards the global eradication of measles, VOA News reports.

High waist circumference associated with greatest risk of death in heart attack survivors

Having a big belly increases the risk of death in heart attack survivors, according to research presented at ESC Congress 2013 by Professor Tabassome Simon and Professor Nicolas Danchin from France.

CDC warns against vaping after series of lung-disease cases

E-cigarette use, also known as vaping, has become popular across all ages. Hundreds of people across the country have been sickened by a severe lung disease linked to e-cigarette use. The Centers for Disease Control and Prevention (CDC) warns the public not to use e-cigarettes due to the potential damage to the lungs.

Phase 2a study results of Aerosurf for prevention of RDS in premature infants published

Discovery Laboratories, Inc., announces the publication of results from its previously-conducted Phase 2a feasibility study of Aerosurf, the Company's aerosolized KL4 surfactant, for the prevention of respiratory distress syndrome in premature infants, in the May 2010 issue of the Journal of Aerosol Medicine and Pulmonary Drug Delivery in the study titled "An Open Label, Pilot Study of Aerosurf Combined with nCPAP to Prevent RDS in Preterm Neonates".

Dr Xavier Hiram Quinones De Jesus, MD - Medicare Ophthalmology in Yauco, PR